Invention Grant
![Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators](/docs/US/2023-06-06/US11667644B2/abs.jpg.600x600.jpg)
- Patent Title: Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
-
Application No.: US17372168Application Date: 2021-07-09
-
Publication No.: US11667644B2Publication Date: 2023-06-06
- Inventor: Wenying Chai , Michael A. Letavic , Kiev S. Ly , Daniel J. Pippel , Dale A. Rudolph , Kathleen C. Sappey , Brad M. Savall , Chandravadan R. Shah , Brock T. Shireman , Akinola Soyode Johnson , Emily M. Stocking , Devin M. Swanson
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: BakerHostetler
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/5377 ; A61K31/506 ; A61K31/428 ; A61K31/498 ; A61K31/4709 ; A61K31/4439 ; A61K31/53
![Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators](/abs-image/US/2023/06/06/US11667644B2/abs.jpg.150x150.jpg)
Abstract:
Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
Public/Granted literature
- US20210347781A1 Disubstituted Octahydropyrrolo[3,4-c]Pyrroles As Orexin Receptor Modulators Public/Granted day:2021-11-11
Information query
